Related references
Note: Only part of the references are listed.The regulation of connective tissue growth factor expression influences the viability of human trabecular meshwork cells
Sabrina Kuespert et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
The interactions of genes, age, and environment in glaucoma pathogenesis
Lance P. Doucette et al.
SURVEY OF OPHTHALMOLOGY (2015)
Multiple roles of the prostaglandin D2 signaling pathway in reproduction
Moira Rossitto et al.
REPRODUCTION (2015)
Genomics and anterior segment dysgenesis: a review
Yoko A. Ito et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2014)
Investigation of Ocular Events Associated with Taprenepag Isopropyl, a Topical EP2 Agonist in Development for Treatment of Glaucoma
Gina M. Yanochko et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2014)
Novel and recurrent PITX3 mutations in Belgian families with autosomal dominant congenital cataract and anterior segment dysgenesis have similar phenotypic and functional characteristics
Hannah Verdin et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Dual effect of prostaglandins on isolated intraocular porcine ciliary arteries
Sidse Kringelholt et al.
ACTA OPHTHALMOLOGICA (2013)
Differential Effects of Prostaglandin E2-Sensitive Receptors on Contractility of Human Ocular Cells That Regulate Conventional Outflow
Jenny W. Wang et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2013)
Connective Tissue Growth Factor Causes Glaucoma by Modifying the Actin Cytoskeleton of the Trabecular Meshwork
Benjamin Junglas et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
C6orf176: a novel possible regulator of cAMP-mediated gene expression
Armin Reitmair et al.
PHYSIOLOGICAL GENOMICS (2012)
A novel, non-stop mutation in FOXE3 causes an autosomal dominant form of variable anterior segment dysgenesis including Peters anomaly
Lance Doucette et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
WDR36 acts as a scaffold protein tethering a G-protein-coupled receptor, Gαq and phospholipase Cβ in a signalling complex
Andreane Cartier et al.
JOURNAL OF CELL SCIENCE (2011)
International Union of Basic and Clinical Pharmacology. LXXXIII: Classification of Prostanoid Receptors, Updating 15 Years of Progress
D. F. Woodward et al.
PHARMACOLOGICAL REVIEWS (2011)
Prostaglandin D2 and sleep/wake regulation
Yoshihiro Urade et al.
SLEEP MEDICINE REVIEWS (2011)
The Role of the Prostaglandin EP4 Receptor in the Regulation of Human Outflow Facility
Lindsay H. Millard et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Effect of Latanoprost on the Expression of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinase 1 on the Ocular Surface
Norihiko Honda et al.
ARCHIVES OF OPHTHALMOLOGY (2010)
Induction of Angiogenic Immediate Early Genes by Activation of FP Prostanoid Receptors in Cultured Human Ciliary Smooth Muscle Cells
Anthony J. Hutchinson et al.
CURRENT EYE RESEARCH (2010)
Prostaglandin E2 receptor subtype EP2-and EP4-regulated gene expression profiling in human ciliary smooth muscle cells
Armin Reitmair et al.
PHYSIOLOGICAL GENOMICS (2010)
Cellular Basis for Bimatoprost Effects on Human Conventional Outflow
W. Daniel Stamer et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2010)
PGF2α stimulates FP prostanoid receptor mediated crosstalk between Ras/Raf signaling and Tcf transcriptional activation
Wei Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Seeing Clearly: The Dominant and Recessive Nature of FOXE3 in Eye Developmental Anomalies
Sibel Ugur Iseri et al.
HUMAN MUTATION (2009)
Prostanoid EP4 Receptor Stimulation Produces Ocular Hypotension by a Mechanism That Does Not Appear to Involve Uveoscleral Outflow
David F. Woodward et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Effects of Prostanoid EP Agonists on Mouse Intraocular Pressure
Tadashiro Saeki et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Prostaglandin D2 induces heme oxygenase-1 mRNA expression through the DP2 receptor
Soisungwan Satarug et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cells
Jiraporn Kuesap et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
FOXC1 is required for cell viability and resistance to oxidative stress in the eye through the transcriptional regulation of FOXO1A
Fred B. Berry et al.
HUMAN MOLECULAR GENETICS (2008)
A new mRNA splice variant coding for the human EP3-I receptor isoform
L. Kotelevets et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2007)
Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke
S. Patrick Nana-Sinkam et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Modulation of ocular inflammatory responses by EP1 receptors in mice
S. Biswas et al.
EXPERIMENTAL EYE RESEARCH (2007)
Genotype-phenotype correlations in Axenfeld-Rieger malformation and glaucoma patients with FOXC1 and PITX2 mutations
M. Hermina Strungaru et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Antagonism of the prostaglandin D-2 receptors DP1 and CRTH2 as an approach to treat allergic diseases
Roy Pettipher et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey
Siv F. E. Nilsson et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells
Dong-Jin Oh et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
The effects of prostaglandin analogues on prostanoid EP1, EP2, and EP3 receptor-deficient mice
Takashi Ota et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Effects of a prostaglandin DP receptor agonist, AL-6598, on aqueous Humor dynamics in a nonhuman primate model of glaucoma
CB Toris et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Prostanoids as pharmacological targets in COPD and asthma
S Rolin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost
DJ Oh et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
Augmented cardiac hypertrophy in response to pressure overload in mice lacking the prostaglandin I2 receptor
A Hara et al.
CIRCULATION (2005)
Identification of a novel adult-onset primary open-angle glaucoma (POAG) gene on 5q22.1
S Monemi et al.
HUMAN MOLECULAR GENETICS (2005)
Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes
NA Sharif et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2004)
Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment
Y Tamini et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
EP2 and EP4 prostanoid receptor signaling
JW Regan
LIFE SCIENCES (2003)
The second PGD2 receptor CRTH2:: structure, properties, and functions in leukocytes
K Nagata et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2003)
Reduction of intraocular pressure and glaucoma progression - Results from the early manifest glaucoma trial
A Heijl et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Vascular activities of prostaglandins and selective prostanoid receptor agonists in human retinal microvessels
CS Spada et al.
EXPERIMENTAL EYE RESEARCH (2002)
Comparison between isopropyl unoprostone and latanoprost by prostaglandin E-2 induction, affinity to prostaglandin transporter, and intraocular metabolism
K Kashiwagi et al.
EXPERIMENTAL EYE RESEARCH (2002)
Prostacyclin-dependent apoptosis mediated by PPARδ
T Hatae et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Roles of prostaglandin I2 and thromboxane A2 in cardiac ischemia-reperfusion injury -: A study using mice lacking their respective receptors
CY Xiao et al.
CIRCULATION (2001)
Increased matrix metalloproteinases 1, 2, and 3 in the monkey uveoscleral outflow pathway after topical prostaglandin F2α-isopropyl ester treatment
DD Gaton et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Phenotypic heterogeneity of CYP1B1:: mutations in a patient with Peters' anomaly
A Vincent et al.
JOURNAL OF MEDICAL GENETICS (2001)
Functional pharmacological evidence for EP2 and EP4 prostanoid receptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells
JY Crider et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2001)
Prostaglandin D2 as a mediator of allergic asthma
T Matsuoka et al.
SCIENCE (2000)
The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs
M Abramovitz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)
Share Paper
